Brief: Cipla Q2 Consol Net Profit 13.51 Bln Rupees IBES EST. 13.47 Bln Rupees
Oct 30 (Reuters) - Cipla Ltd CIPL.NS: CIPLA Q2 CONSOL NET PROFIT 13.51 BILLION RUPEES; IBES EST. 13.47 BILLION RUPEES CIPLA Q2 CONSOL TOTAL REVENUE FROM OPERATIONS 75.89 BILLION RUPEES, IBES EST. 74.30 BILLION RUPEES Source text: [ID:] Further company coverage: CIPL.NS ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cipla
See all newsFactbox: Global healthcare companies invest billions to boost US presence
Brief: Cipla, Qilu Pharmaceutical Partner For Licensing, Supply Of Biosimilar To Keytruda In US
India's Cipla, China's Qilu partner for US launch of Merck's Keytruda biosimilar
Brief: Cipla Enters Exclusive Partnership With Qilu For Keytruda Biosimilar In US
Brief: Cipla and SBP Group Sign Exclusive Licensing Agreement For HER2 Bispecific Antibody-Drug Conjugate